欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0481/003
药品名称
Fosrenol
活性成分
lanthanum(III)carbonate 750.0 mg
剂型
Chewable tablet
上市许可持有人
Takeda Pharmaceuticals International AG Ireland Branch
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
Greece (GR)
Norway (NO)
Finland (FI)
Latvia (LV)
Estonia (EE)
FOSRENOL
Hungary (HU)
FOSRENOL 750 mg rágótabletta
Bulgaria (BG)
Fosrenol
Cyprus (CY)
Slovakia (SK)
Fosrenol 750 mg žuvacie tablety
Slovenia (SI)
Malta (MT)
Lithuania (LT)
FOSRENOL 750 mg kramtomosios tabletės
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
Ireland (IE)
Austria (AT)
Fosrenol 750 mg Kautabletten
France (FR)
Spain (ES)
许可日期
2005/03/01
最近更新日期
2024/07/18
药物ATC编码
V03AE03 lanthanum carbonate
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier [Article 8.3(i)]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0481/003_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0481/003_Final SPC
Date of last change:2014/01/15
PAR
|
SE/H/0481/003_PAR
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase